CAS: 1254473-64-7
1H-Pyrazole-1-ethanol, 4-[(1E)-2-[5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-
CAS:1254473-64-7
Formula:
C21H19Cl2N5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
444.3139
Ref: IN-DA000NOR
1g | To inquire | ||
5mg | 71.00 € | ||
10mg | 114.00 € | ||
25mg | 186.00 € | ||
50mg | 226.00 € | ||
100mg | 510.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
LY2874455
CAS:1254473-64-7
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Formula:
C21H19Cl2N5O2
Purity:
97.22% - 99.46%
Color and Shape:
Solid
Molecular weight:
444.31
Ref: TM-T2361
1mg | 63.00 € | ||
2mg | 90.00 € | ||
5mg | 125.00 € | ||
10mg | 193.00 € | ||
25mg | 343.00 € | ||
50mg | 510.00 € | ||
100mg | 732.00 € | ||
1mL*10mM (DMSO) | 140.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
LY 2874455
CAS:1254473-64-7
Inhibitor of FGFR kinase
Formula:
C21H19Cl2N5O2
Purity:
(%) Min. 98%
Molecular weight:
443.09158
Ref: 3D-FL137697
10mg | 457.00 € | ||
50mg | 1,277.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
LY 2874455
Controlled ProductCAS:1254473-64-7
Applications LY 2874455 is a pan-FGFR inhibitor which remain the focus of research for use …
Formula:
C21H19Cl2N5O2
Color and Shape:
Neat
Molecular weight:
444.31
Ref: TR-L486580
1mg | 181.00 € | ||
5mg | 329.00 € | ||
25mg | 619.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025